Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.83 |
| ▸ | CPA3 | P15088 | 3/20 | 0.78 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.72 |
| ▸ | CPA1 | P15085 | 7/20 | 0.70 |
| ▸ | CPB1 | P15086 | 1/20 | 0.70 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.70 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.63 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.63 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.63 |
| ▸ | MME | P08473 | 1/20 | 0.59 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.58 |
| ▸ | ALPI | P09923 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | XIAP | P98170 | 1/20 | 0.57 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12494233 | 1.00 | CYP1A2 (0.83) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL19821208 | 1.00 | CYP1A2 (0.83) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| Hydrochloric Acid SCHEMBL6717346 | 0.98 | CYP1A2 (0.79) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL11664393 | 0.91 | FOLH1 (0.79) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL4664822 | 0.91 | CYP1A2 (1.00) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL12494839 | 0.90 | CYP1A2 (0.68) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL12494636 | 0.90 | CYP1A2 (0.68) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL12494703 | 0.90 | CYP1A2 (0.68) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL3276235 | 0.90 | CYP1A2 (0.68) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL12493651 | 0.90 | CYP1A2 (0.74) | CYP1A2CPA3FOLH1CPA1CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106083570-B | A kind of preparation method of (2R, 5R) 2,5 dibenzyl adipic acid | 宁波九胜创新医药科技有限公司 | 2018-04-10 | — | — | CN | claimed |
| CN-106083570-A | A kind of preparation method of (2R, 5R) 2,5 dibenzyl adipic acid | 宁波九胜创新医药科技有限公司 | 2016-11-09 | — | — | CN | claimed |
| CN-121318694-A | Preparation method of 2, 5-dibenzyl adipic acid | 研旭科技(苏州)有限公司 | 2026-01-13 | — | — | CN | disclosed |
| CN-121318694-A | Preparation method of 2, 5-dibenzyl adipic acid | 研旭科技(苏州)有限公司 | 2026-01-13 | — | — | CN | disclosed |
| CN-106083570-B | A kind of preparation method of (2R, 5R) 2,5 dibenzyl adipic acid | 宁波九胜创新医药科技有限公司 | 2018-04-10 | — | — | CN | disclosed |
| CN-106083570-A | A kind of preparation method of (2R, 5R) 2,5 dibenzyl adipic acid | 宁波九胜创新医药科技有限公司 | 2016-11-09 | — | — | CN | disclosed |
| US-20140051888-A1 | NOVEL STEREOISOMERIC MIXTURES, SYNTHESIS AND USES THEREOF | AMPAC FINE CHEMICALS LLC (US) | 2014-02-20 | — | — | US | disclosed |
| US-20140051888-A1 | NOVEL STEREOISOMERIC MIXTURES, SYNTHESIS AND USES THEREOF | AMPAC FINE CHEMICALS LLC (US) | 2014-02-20 | — | — | US | disclosed |
| US-20140051888-A1 | NOVEL STEREOISOMERIC MIXTURES, SYNTHESIS AND USES THEREOF | AMPAC FINE CHEMICALS LLC (US) | 2014-02-20 | — | — | US | disclosed |
| US-6673880-B2 | ETHYLENE (CO)POLYMERS HAVING LOW MOLECULAR WEIGHTS AND NARROW MOLECULAR WEIGHT DISTRIBUTIONS | BASELL TECHNOLOGY COMPANY B.V. (NL) | 2004-01-06 | — | — | US | disclosed |
| EP-0942011-B1 | Multi-stage process for the polymerization of olefins | BASELL POLIOLEFINE SPA (IT) | 2003-05-14 | — | — | EP | disclosed |
| EP-0941997-B1 | Bridged zirconocene compounds, process for their preparation, and their use as catalyst components in the polymerization of olefins | BASELL POLYOLEFINE GMBH (DE) | 2002-12-18 | — | — | EP | disclosed |
| US-6479609-B1 | Multi-stage process for the polymerization of olefins | BASELL TECHNOLOGY COMPANY BV (NL) | 2002-11-12 | — | — | US | disclosed |
| US-20020039962-A1 | Bridged zirconocene compounds, process for their preparation and their use as catalyst components in the polymerization of olefins | MONTELL TECHNOLOGY COMPANY B.V. | 2002-04-04 | — | — | US | disclosed |
| US-6306791-B2 | Bridged zirconocene compounds, process for their preparation and their use as catalyst components in the polymerization of olefins | BASELL TECHNOLOGY COMPANY BV (NL) | 2001-10-23 | — | — | US | disclosed |
| US-20010014751-A1 | Bridged zirconocene compounds, process for their preparation and their use as catalyst components in the polymeriaztion of olefins | MONTELL TECHNOLOGY COMPANY B.V. | 2001-08-16 | — | — | US | disclosed |
| US-6262195-B1 | POLYMERIZING ETHYLENE OPTIONALLY WITH ALPHA-OLEFIN IN PRESENCE OF TITANIUM OR VANADIUM COMPOUND CATALYST; CONTACTING PRODUCT WITH COMPOUND TO DEACTIVATE CATALYST, ZIRCOCENE CATALYST AND COCATALYST TO FURTHER POLYMERIZE | MONTELL TECHNOLOGY COMPANY BV (NL) | 2001-07-17 | — | — | US | disclosed |
| US-6232484-B1 | Bridged zirconocene compounds, process for their preparation and their use as catalyst components in the polymerization of olefins | MONTELL TECHNOLOGY B.V. (NL) | 2001-05-15 | — | — | US | disclosed |
| EP-0941997-A2 | Bridged zirconocene compounds, process for their preparation, and their use as catalyst components in the polymerization of olefins | Montell Technology Company bv (NL) | 1999-09-15 | — | — | EP | disclosed |
| EP-0942011-A1 | Multi-stage process for the polymerization of olefins | Montell Technology Company bv (NL) | 1999-09-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140051888-A1 | NOVEL STEREOISOMERIC MIXTURES, SYNTHESIS AND USES THEREOF | DDT, DPYD, DHPS | CYP1A2 559/4885CPA3 3911/4885FOLH1 96/4885 |
| US-20020039962-A1 | Bridged zirconocene compounds, process for their preparation and their use as catalyst components in the polymerization of olefins | ZRANB2, ZKSCAN2, ZCCHC8 | CYP1A2 3435/4885CPA3 4615/4885FOLH1 4644/4885 |
| US-20010014751-A1 | Bridged zirconocene compounds, process for their preparation and their use as catalyst components in the polymeriaztion of olefins | ZRANB2, ZKSCAN2, ZNF787 | CYP1A2 2297/4885CPA3 3697/4885FOLH1 4293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.